Stratasys (SSYS) has disclosed a new risk, in the Environmental / Social category.
Stratasys faces considerable risk from stringent environmental, health and safety regulations impacting their international product exports and operations. Compliance with laws such as TSCA, REACH, and various export control regulations necessitates significant expenditure and diligence. Non-compliance could result in substantial fines and liability, particularly with the inclusion of medical device regulations like the U.S. FDA Code of Federal Regulations. These risks, if not managed effectively, could materially and adversely affect Stratasys’s financial health and operational outcomes.
The average SSYS stock price target is $17.50, implying 39.11% upside potential.
To learn more about Stratasys’ risk factors, click here.
